Cambridge, USA-based biotech Sage Therapeutics yesterday announced that, while rejecting an unsolicited takeover offer, its ...

Charles River Laboratories International, Inc. will release fourth-quarter and full-year 2024 financial results and provide 2025 guidance on Wednesday, February 19th, before the market opens. A ...

To watch Kennedy's confirmation hearing, viewers can look to the Senate Finance Committee website on Wednesday and the Senate ...

Here are today's Five Things You Need to Know in Boston business news, including earthquakes, an AI bubble, stock crash, spurned suitors and multibillion-dollar M&A deals.

The Trump administration has withdrawn a plan to ban menthol cigarettes in the U.S., in a setback to health regulators and ...

DNOW Inc. has scheduled a conference call to discuss the results for the fourth quarter and full-year 2024 on Thursday, February 13, 2025 at 8:00 am (US Central Time). Financial results for the fourth ...

M&A specialists are eyeing a robust list of likely US takeover candidates, with a buoyant economy, strong buyer appetite and ...

While some spoke of the medicinal benefits of gomutra or gaumutra, a section of modern scientists did not support its use for ...

To help you understand how AI and other new technologies are affecting energy consumption, trends in this space and what we ...

Sage Therapeutics rejected a takeover offer from Biogen ( BIIB) and said it started a process to review its strategic ...

Sage Therapeutics, Inc. filed an 8-K report with the Securities and Exchange Commission. The filing disclosed that the Board of Directors of Sage Therapeutics has commenced a strategic review process ...

Sage Therapeutics announced its boards unanimous rejection of Biogens $469 million acquisition offer, stating the proposal ...